Prescient Therapeutics Limited (ASX: PTX) – Next Gen CAR-T Platform a Potential Game Changer


August 24, 2020
 / 
PTX is a clinical stage oncology company with a focus on developing targeted and cellular cancer therapies. Targeted therapies are a focus for anticancer drug development, with the aim of personalising treatment based on a person’s genes and proteins to prevent, diagnose and treat the disease